DRAW-TO-THAW
Live / Applied — Second extension granted (statement of use) (as of 12 Dec 2025)
What this means for you
Not registered yet, but its 12 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98309999
- Mark type
- Stylized text
- Filed
- 12 Dec 2023
- Published for opposition
- 05 Nov 2024
- Attorney of record
- CYNTHIA JOHNSON WALDEN
Goods and services
- Class 005 — Pharmaceuticals: Products to support and manage transfusion medicine and regenerative medicine from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products, namely cord blood, leukopaks, buffy coats for medical use, antibody positive blood plasma, blood components for medical purposes, namely, phenotyped red cell units and monoclonal antibodies, cord blood all for use in medical diagnoses and treatment; mononuclear cells for medical use, progenitor cells for medical use, antibody preparations for medical use in medical clinical trials and medical purposes
- Class 035 — Advertising and business services: Providing independent review of clinical trials for business purposes
- Class 039 — Transportation and storage services: Storage of blood and stem cells for medical use; human stem cell storage for medical use
- Class 040 — Treatment of materials: Cryopreservation of human cells
- Class 042 — Scientific and technological services: Pharmaceutical research services and conducting pharmaceutical clinical trials for others; medical research laboratory services, namely, cell processing services for use by others
- Class 044 — Medical, beauty and agricultural services: Blood bank services; tissue bank services; collection and preservation of human blood, red blood cells, plasma and bone marrow; apheresis, namely, removal, treatment, and processing of human blood; T cell isolation services, namely, medical services involving the removal, treatment, and processing of human blood to isolate t cells
Owner
- New York Blood Center, Inc., New York, NY, US
- New York Blood Center, Inc., New York, NY, US
Prosecution history
- 13 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2025 — SOU EXTENSION 2 GRANTED
- 12 Dec 2025 — SOU EXTENSION 2 FILED
- 12 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2025 — SOU EXTENSION 1 GRANTED
- 17 Jun 2025 — SOU EXTENSION 1 FILED
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Dec 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Dec 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED